ENDRA Life Sciences (NDRA) Reports In-Line Q1 EPS

ENDRA Life Sciences (NASDAQ: NDRA) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07).

For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Corpay agrees to $100M FTC settlement over marketing practices
• Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike